⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18768832 | 0.70 | — | — | |
| SCHEMBL21921082 | 0.70 | — | — | |
| SCHEMBL153031 | 0.69 | — | — | |
| SCHEMBL22435560 | 0.68 | — | — | |
| SCHEMBL8265707 | 0.67 | — | — | |
| SCHEMBL24836130 | 0.65 | ALDH1A1 (0.37) | — | |
| SCHEMBL571235 | 0.65 | — | — | |
| SCHEMBL571234 | 0.65 | — | — | |
| SCHEMBL23544254 | 0.64 | — | — | |
| SCHEMBL7946818 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11701370-B2 | Phosphonium ion channel blockers and methods for use | Nocion Therapeutics, Inc. (US) | 2023-07-18 | — | — | US | disclosed |
| US-20210128589-A1 | PHOSPHONIUM ION CHANNEL BLOCKERS AND METHODS FOR USE | Nocion Therapeutics, Inc. | 2021-05-06 | — | — | US | disclosed |